Canada’s premiers (the leaders of provincial government), if they have any breath left after complaining about Ottawa at their l

admin2022-12-08  45

问题     Canada’s premiers (the leaders of provincial government), if they have any breath left after complaining about Ottawa at their late July annual meeting, might spare a moment to do something, to reduce health-care costs.
    They’re all groaning about soaring health budgets, the fastest-growing components of which are pharmaceutical costs.
    【B1】________
    What to do? Both the Romanow commission and the Kirby committee on health care—to say nothing of reports from other experts—recommended the creation of a national drug agency. Instead of each province having its own list of approved drugs, bureaucracy, procedures and limited bargaining power, all would pool resources, work with Ottawa, and create a national institution.
    【B2】________
    But "national" doesn’t have to mean that "National" could mean interprovincial—provinces combining efforts to create one body.
    Either way, one benefit of a "national" organization would be to negotiate better prices, if possible, with drug manufacturers. Instead of having one province—or a series of hospitals within a province— negotiate a price for a given drug on the provincial list, the national agency would negotiate on behalf of all provinces.
    Rather than, say, Quebec, negotiating on behalf of seven million people, the national agency would negotiate on behalf of 31 million people. Basic economics suggests the greater the potential consumers, the higher the likelihood of a better price.
    【B3】________
    A small step has been taken in the direction of a national agency with the creation of the Canadian Co-ordinating Office for Health Technology Assessment, funded by Ottawa and the provinces. Under it, a Common Drug Review recommends to provincial lists which new drugs should be included predictably and regrettably, Quebec refused to join.
    A few premiers are suspicious of any federal-provincial deal-making. They (particularly Quebec and Alberta) just want Ottawa to fork over additional billions with few, if any strings attached. That’s one reason why the idea of a national list hasn’t gone anywhere, while drug costs keep rising fast.
    【B4】________
    Premiers love to quote Mr. Romanow’s report selectively, especially the parts about more federal money. Perhaps they should read what he had to say about drugs: "A national drug agency would provide governments more influence on pharmaceutical companies in order to try to constrain the ever-increasing cost of drugs."
    【B5】________
    So when the premiers gather in Niagara Falls to assemble their usual complaint list, they should also get cracking about something in their jurisdiction that would help their budgets and patients.
    A ) Quebec’s resistance to a national agency is provincialist ideology. One of the first advocates for a national list was a researcher at Laval University. Quebec’s Drug Insurance Fund has seen its costs skyrocket with annual increases from 14.3 percent to 26.8 percent!
    B ) Or they could read Mr. Kirby’s report: "The substantial buying power of such an agency would strengthen the public prescription-drug insurance plans to negotiate the lowest possible purchase prices from drug companies."
    C) What does "national" mean? Roy Romanow and Senator Michael Kirby recommended a federal-provincial body much like the recently created National Health Council.
    D ) The problem is simple and stark: health-care costs have been, are, and will continue to increase faster than government revenues.
    E ) According to the Canadian Institute for Health Information, prescription drug costs have risen since 1997 at twice the rate of overall health-care spending. Part of the increase comes from drugs being used to replace other kinds of treatment. Part of it arises from new drugs costing more than older kinds. Part of it is higher prices.
    F ) So, if the provinces want to run the health-care show, they should prove they can run it, starting with an interprovincial health list that would end duplication, save administrative costs, prevent one province from being played off against another, and bargain for better drug prices.
    G ) Of course, the pharmaceutical companies will scream. They like divided buyers; they can lobby better that way. They can use the threat of removing jobs from one province to another. They can hope that, if one province includes a drug on its list, the pressure will cause others to include it on theirs. They wouldn’t like a national agency, but self-interest would lead them to deal with it.
【B5】

选项

答案B

解析 本题可以组合运用上下文逻辑关系定位法、复现结构定位法、代词指代关系定位法和排比结构衔接法。第5题之前的段落信息中提到了一类人:premiers(各省的省长),作者认为they should read what he had to say about drugs:“A national drug agency would provide governments more influence on pharmaceutical companies in order to try to constrain the ever-increasing cost of drugs.”(……“一个全国性的机构可以赋予政府对制药公司更大的影响力,去控制日益上涨的药品价格。”)根据上下文的就近原则,填入第5题的信息也要与此信息相关。选项B)中出现了Or they could read Mr.Kirby’s report:“The substantial buying power of such an agency would strengthen the public prescription—drug insurance plans to negotiate the lowest possible purchase prices from drug companies.”首先,or表明上下文并列关系,选项B)与第5题之前的段落信息确实可以形成并列关系;其次,选项B)中出现了与第5题之前的段落信息中出现的they should read类似的结构they could read,带有一定的排比结构的特征,而且从代词指代关系的角度,选项B)中出现的they与第5题之前的段落信息中出现的they一样,均可指代第5题之前的段落信息中提到的一类人:premiers;最后,从内容上判断选项B)中的信息也是在强调: “这个全国性机构的强大的购买力将会使得处方药保险公司从制药公司获得尽可能低的价格。”这个信息与第5题之前的段落信息具有相近性,所以可以衔接在一起。
转载请注明原文地址:https://kaotiyun.com/show/QlMD777K
0

最新回复(0)